A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma

Ixazomib is the only oral proteasome inhibitor used in relapsed/refractory myeloma. Cutaneous side effects due to ixazomib have been documented in the literature; however, cutaneous necrotizing vasculitis is extremely rare. We describe a case of a 74-year-old man with relapsed multiple myeloma who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Heather, Shenouda, Mina, Dahshan, Deena, Sonnier, George, Lebowicz, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855061/
https://www.ncbi.nlm.nih.gov/pubmed/31781426
http://dx.doi.org/10.1155/2019/6061484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855061/
https://www.ncbi.nlm.nih.gov/pubmed/31781426
http://dx.doi.org/10.1155/2019/6061484

Ejemplares similares